Phosphoinositides signalling in cancer: focus on PI3K and PLC.
Queen Mary University of London, Barts and The London School of Medicine and Dentistry, Blizard Institute, Centre for Diabetes, Inositide Signalling Group, London E1 2AT, UK.
Claudio
C
Raimondi
Marco
M
Falasca
D000818:Animals; D006801:Humans; D009369:Neoplasms / Q000201:enzymology* / Q000378:metabolism*; D019869:Phosphatidylinositol 3-Kinases / Q000235:genetics / Q000378:metabolism*; D010716:Phosphatidylinositols / Q000378:metabolism*; D015398:Signal Transduction / Q000235:genetics / Q000502:physiology; D010738:Type C Phospholipases / Q000235:genetics / Q000378:metabolism*
D010716:Phosphatidylinositols; D019869:Phosphatidylinositol 3-Kinases; D010738:Type C Phospholipases